By Times of Israel

Food tech startup recently raised $120 million with investors to build its production capabilities.

Health Ministry-led research also shows teens who got their shots over four months ago only slightly better off than unvaccinated; hospitalizations among kids reportedly on rise.

Israeli food company partners with biotech firm Pluristem Therapeutics to launch lab-grown meat, aiming at a quick trip to market, followed by animal-free dairy, fish

Without comprehensive strategy and funding, country will have ‘initiated’ field but will not reap benefits, according to Good Food Institute Israel

Ra’anana-based Cannbis looks to become go-to information resource and online marketplace for licensed consumers, now numbering over 100,000.

Part-protest competition organized by Israel Women’s Network awards prizes for social entrepreneurship.

Phase II trial of MesenCure among 30 patients with serious coronavirus cases shows almost all lived and had shorter hospital stays than controls, but expert says more data needed.

Currency’s strength against dollar reaches level not seen in over 2 decades, and experts predict it is not going to stop there

Seven Israeli firms, most of them state-owned, went to the defense exhibition in Dubai, one of the premier weapons shows in the world.

A critical mass of mega-valued global tech companies based in Israel may create a whole new local ecosystem in the coming years.

Tel Aviv-based Roie Galitz, who is drawn to frozen landscapes, warns that the disappearance of polar bears is the world’s ‘canary in the coalmine’.

New data platform will allow doctors worldwide to input data from biopsies to find the best-matching immunotherapy for particular patients.

Justice Minister Gideon Sa’ar says gap between existing legislation and tech advancements only widening, will seek to formulate effective measures to protect privacy, economy.

Top US health official Dr. Anthony Fauci says Israel to soon have more information on myocarditis, an inflammation of the heart in younger males.

Tumors in mice lost half their size when injected with eosinophils, best known for inducing allergies; promising results also seen in human tumor cells in vitro.